摘要 |
<p>Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders. The compounds have the following structure (I): (R4)s (R 2)n N~ X1-X2 (CR1aCRlb)q 1~ N R1-lm 1 O R3 (I) including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, q, s, R1, R1a, R1b, R2, R3, R4, X1 X2 and X3 are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.</p> |
申请人 |
NEUROCRINE BIOSCIENCES, INC.;CHEN, CHEN;TRAN, JOE, AHN;TUCCI, FABIO, C.;CHEN, WEI-CHUAN, C.,;JIANG, WANLONG;MARINKOVIC, DRAGAN;ARELLANO, MELISSA;WHITE, NICOLE |
发明人 |
CHEN, CHEN;TRAN, JOE, AHN;TUCCI, FABIO, C.;CHEN, WEI-CHUAN, C.,;JIANG, WANLONG;MARINKOVIC, DRAGAN;ARELLANO, MELISSA;WHITE, NICOLE |